- Home
- PPBT vs BTBD Comparison
PPBT vs BTBD Comparison
Compare PPBT & BTBD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PPBT
- BTBD
- Stock Information
- Founded
- PPBT 2010
- BTBD 1987
- Country
- PPBT Israel
- BTBD United States
- Employees
- PPBT N/A
- BTBD N/A
- Industry
- PPBT Biotechnology: Pharmaceutical Preparations
- BTBD Restaurants
- Sector
- PPBT Health Care
- BTBD Consumer Discretionary
- Exchange
- PPBT Nasdaq
- BTBD Nasdaq
- Market Cap
- PPBT 6.5M
- BTBD 6.6M
- IPO Year
- PPBT N/A
- BTBD 2021
- Fundamental
- Price
- PPBT $2.27
- BTBD $1.00
- Analyst Decision
- PPBT Strong Buy
- BTBD
- Analyst Count
- PPBT 1
- BTBD 0
- Target Price
- PPBT $33.00
- BTBD N/A
- AVG Volume (30 Days)
- PPBT 286.5K
- BTBD 2.6K
- Earning Date
- PPBT 05-23-2025
- BTBD 05-15-2025
- Dividend Yield
- PPBT N/A
- BTBD N/A
- EPS Growth
- PPBT N/A
- BTBD N/A
- EPS
- PPBT N/A
- BTBD N/A
- Revenue
- PPBT N/A
- BTBD $14,864,398.00
- Revenue This Year
- PPBT N/A
- BTBD N/A
- Revenue Next Year
- PPBT N/A
- BTBD N/A
- P/E Ratio
- PPBT N/A
- BTBD N/A
- Revenue Growth
- PPBT N/A
- BTBD 4.71
- 52 Week Low
- PPBT $2.00
- BTBD $1.05
- 52 Week High
- PPBT $20.60
- BTBD $2.02
- Technical
- Relative Strength Index (RSI)
- PPBT 40.43
- BTBD 36.33
- Support Level
- PPBT $2.18
- BTBD $1.05
- Resistance Level
- PPBT $2.41
- BTBD $1.08
- Average True Range (ATR)
- PPBT 0.20
- BTBD 0.03
- MACD
- PPBT -0.01
- BTBD -0.00
- Stochastic Oscillator
- PPBT 27.96
- BTBD 0.00
About PPBT Purple Biotech Ltd.
Purple Biotech Ltd is a clinical-stage company focused on advancing first-in-class therapies to overcome tumor immune evasion and drug resistance, and to create treatments for people with cancer. Its oncology pipeline includes NT219: A dual inhibitor, small molecule that simultaneously targets Insulin Receptor Substrate 1 and 2 (IRS1/2) and Signal Transducer and Activator of Transcription (STAT3), two survival signal transduction pathways driving the development of cancer drug resistance. and CM24: is a humanized monoclonal antibody designed to block the interactions of Carcinoembryonic Antigen Related Cell Adhesion Molecule 1 (CEACAM1), a glycoprotein that plays a key role in immune regulation, cell adhesion, and tumor progression, CAPTN3.
About BTBD BT Brands Inc.
BT Brands Inc operates and owns a fast-food restaurant called Burger Time. The company also operates in Minnesota as a franchisee of Dairy Queen. It offers a variety of burgers and other affordably priced foods such as chicken sandwiches, pulled pork sandwiches, chicken chunks, side dishes, and soft drinks.